Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2018, Article ID 1039423, 6 pages
https://doi.org/10.1155/2018/1039423
Research Article

Prevalence of Sero-Molecular Markers of Hepatitis C and B Viruses among Patients with β-Thalassemia Major in Northern West Bank, Palestine

1Department of Medical Lab Sciences, Arab American University, Palestine, State of Palestine
2Al-Quds Public Health Society, Jerusalem, State of Palestine

Correspondence should be addressed to Kamal Dumaidi; ude.juaa@idiamud.lamak

Received 6 May 2018; Revised 17 July 2018; Accepted 5 August 2018; Published 5 September 2018

Academic Editor: Lucia Lopalco

Copyright © 2018 Kamal Dumaidi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Viprakasit, C. Lee-Lee, Q. T. Chong, K. H. Lin, and A. Khuhapinant, “Iron chelation therapy in the management of thalassemia: the Asian perspectives,” International Journal of Hematology, vol. 90, no. 4, pp. 435–445, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. T. Taher, Z. K. Otrock, I. Uthman, and M. D. Cappellini, “Thalassemia and hypercoagulability,” Blood Reviews, vol. 22, no. 5, pp. 283–292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Colah, A. Gorakshakar, and A. Nadkarni, “Global burden, distribution and prevention of beta-thalassemias and hemoglobin E disorders,” Expert Review of Hematology, vol. 3, no. 1, pp. 103–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. V. De Sanctis, C. Kattamis, D. Canatan et al., “beta-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 9, no. 1, Article ID e2017018, 2017. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Skarmoutsou, I. Papassotiriou, J. Traeger-Synodinos et al., “Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels,” Haematologica, vol. 88, no. 6, pp. 631–636, 2003. View at Google Scholar
  6. M. Karimi and A. A. Ghavanini, “Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz, Iran,” Journal of Paediatrics and Child Health, vol. 37, no. 6, pp. 564–566, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Al Kanaani, S. Mahmud, S. P. Kouyoumjian, and L. J. Abu-Raddad, “The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses,” Royal Society Open Science, vol. 5, no. 4, Article ID 180257, 2018. View at Publisher · View at Google Scholar
  8. S. Mahmud, V. Akbarzadeh, and L. J. Abu-Raddad, “The epidemiology of hepatitis C virus in Iran: systematic review and meta-analyses,” Scientific Reports, vol. 8, no. 1, p. 150, 2018. View at Publisher · View at Google Scholar · View at Scopus
  9. S. P. Kouyoumjian, H. Chemaitelly, and L. J. Abu-Raddad, “Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions,” Scientific Reports, vol. 8, no. 1, p. 1661, 2018. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Omar, K. Salama, S. Adolf, G. S. El-Saeed, N. Abdel Ghaffar, and N. Ezzat, “Major risk of blood transfusion in hemolytic anemia patients,” Blood Coagulation and Fibrinolysis, vol. 22, no. 4, pp. 280–284, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. T. Atwa and W. Y. Abdel Wahed, “Transfusion transmitted infections in frequently transfused thalassemic children living in Fayoum Governorate, Egypt: current prevalence and risk factors,” Journal of Infection and Public Health, vol. 10, no. 6, pp. 870–874, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. R. A. Mahmoud, A. A. El-Mazary, and A. Khodeary, “Seroprevalence of hepatitis C, hepatitis B, cytomegalovirus, and human immunodeficiency viruses in multitransfused thalassemic children in upper Egypt,” Advances in Hematology, vol. 2016, Article ID 9032627, 7 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. K. M. Salama, O. M. Ibrahim, A. M. Kaddah, S. Boseila, L. A. Ismail, and M. M. Hamid, “Liver enzymes in children with beta-thalassemia major: correlation with iron overload and viral hepatitis,” Open Access Macedonian Journal of Medical Sciences, vol. 3, no. 2, pp. 287–292, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Assarehzadegan, M. G. Boroujerdnia, and K. Zandian, “Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in ahvaz, southwest iran,” Iranian Red Crescent Medical Journal, vol. 14, no. 8, pp. 470–474, 2012. View at Google Scholar
  15. M. Jafroodi, A. Davoudi-Kiakalayeh, Z. Mohtasham-Amiri, A. A. Pourfathollah, and A. Haghbin, “Trend in prevalence of hepatitis C virus infection among beta-thalassemia major patients: 10 years of experience in Iran,” International Journal of Preventive Medicine, vol. 6, no. 1, p. 89, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Valizadeh, M. Noroozi, S. Hejazi, S. Nateghi, and A. Hashemi, “Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency viruses among thalassemia patients in west north of Iran,” Iranian Journal of Pediatric Hematology and Oncology, vol. 5, no. 3, pp. 145–148, 2015. View at Google Scholar
  17. H. Qureshi, K. M. Bile, R. Jooma, S. E. Alam, and H. U. Afridi, “Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures,” Eastern Mediterranean Health Journal, vol. 16, pp. S15–S23, 2010. View at Publisher · View at Google Scholar
  18. R. Ahmed Kiani, M. Anwar, U. Waheed, M. J. Asad, S. Abbasi, and H. Abbas Zaheer, “Epidemiology of transfusion transmitted infection among patients with beta-thalassaemia major in Pakistan,” Journal of Blood Transfusion, vol. 2016, Article ID 8135649, 5 pages, 2016. View at Publisher · View at Google Scholar
  19. I. Tarazi, E. Al Najjar, N. Lulu, and M. Sirdah, “Obligatory premarital tests for beta-thalassaemia in the Gaza Strip: evaluation and recommendations,” International Journal of Laboratory Hematology, vol. 29, no. 2, pp. 111–118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. Ministry of Health, Health Annual Report-Palestine 2015, Ministry of Health, Ramallah, Palestine, 2016.
  21. F. Andre, “Hepatitis B epidemiology in Asia, the middle east and Africa,” Vaccine, vol. 18, pp. S20–22, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. A. D. Jack, A. J. Hall, N. Maine, M. Mendy, and H. C. Whittle, “What level of hepatitis B antibody is protective?” Journal of Infectious Diseases, vol. 179, no. 2, pp. 489–492, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. S. G. Selabe, A. Lukhwareni, E. Song, Y. G. Leeuw, R. J. Burnett, and M. J. Mphahlele, “Mutations associated with lamivudine-resistance in therapy-naive hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients,” Journal of Medical Virology, vol. 79, no. 11, pp. 1650–1654, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. El-Kader, A. A. Elmanama, and B. M. Ayesh, “Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine,” Virology Journal, vol. 7, no. 1, p. 210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Chemaitelly, K. Chaabna, and L. J. Abu-Raddad, “The epidemiology of hepatitis C virus in the fertile crescent: systematic review and meta-analysis,” PLoS One, vol. 10, no. 8, Article ID e0135281, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Chemin and C. Trepo, “Clinical impact of occult HBV infections,” Journal of Clinical Virology, vol. 34, pp. S15–S21, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. C. S. Keechilot, V. Shenoy, A. Kumar et al., “Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India,” Pathogens and Global Health, vol. 110, no. 7-8, pp. 287–291, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Samimi-Rad, F. Asgari, M. Nasiritoosi et al., “Patient-to-patient transmission of hepatitis C at Iranian Thalassemia centers shown by genetic characterization of viral strains,” Hepatitis Monthly, vol. 13, no. 1, Article ID e7699, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. S. A. Al-Sweedan, S. Jaradat, K. Amer, W. Hayajneh, and H. Haddad, “Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with beta-thalassemia major,” Turkish Journal of Hematology, vol. 28, no. 1, pp. 47–51, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Sukeepaisalncharoen, U. Peansukwech, and K. Sawanyawisuth, “Who should be checked for hepatitis C virus infection in endemic areas?” Asian Pacific Journal of Tropical Medicine, vol. 9, no. 10, pp. 991–994, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. M. K. Arababadi, G. Hassanshahi, H. Yousefi, E. R. Zarandi, M. Moradi, and M. Mahmoodi, “No detected hepatitis B virus-DNA in thalassemic patients infected by hepatitis C virus in Kerman province of Iran,” Pakistan Journal of Biological Sciences, vol. 11, no. 13, pp. 1738–1741, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. O. Shaker, A. Ahmed, I. Abdel Satar, H. El Ahl, W. Shousha, and W. Doss, “Occult hepatitis B in Egyptian thalassemic children,” ournal of Infection in Developing Countries, vol. 6, no. 4, pp. 340–346, 2012. View at Publisher · View at Google Scholar
  33. M. Alaidarous, R. K. Choudhary, M. I. Waly et al., “The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia,” Journal of Infection and Public Health, 2018, In press. View at Google Scholar
  34. M. A. Carneiro, R. M. Martins, S. A. Teles et al., “Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods,” Memórias do Instituto Oswaldo Cruz, vol. 96, no. 6, pp. 765–769, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. Juniastuti, T. Utsumi, Nasronudin et al., “High rate of seronegative HCV infection in HIV-positive patients,” Biomedical Reports, vol. 2, no. 1, pp. 79–84, 2014. View at Publisher · View at Google Scholar
  36. N. Jindal, D. Soin, P. Grover et al., “Hepatitis C virus (HCV) infection among seronegative patients undergoing haemodialysis in a remotely located tertiary care hospital of northern India: value of HCV-RNA and genotypes,” Journal of Clinical and Diagnostic Research, vol. 9, no. 12, pp. DC10–DC12, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. A. El-Sherif, A. Elbahrawy, A. Aboelfotoh et al., “High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysis,” Hemodialysis International, vol. 16, no. 3, pp. 420–427, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. W. S. Lee, C. M. Teh, and L. L. Chan, “Risks of seroconversion of hepatitis B, hepatitis C and human immunodeficiency viruses in children with multitransfused thalassaemia major,” Journal of Paediatrics and Child Health, vol. 41, no. 5-6, pp. 265–268, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Farmakis, A. Giakoumis, E. Polymeropoulos, and A. Aessopos, “Pathogenetic aspects of immune deficiency associated with beta-thalassemia,” Medical Science Monitor, vol. 9, no. 1, pp. RA19–RA22, 2003. View at Google Scholar
  40. E. Hussein, “Evaluation of infectious disease markers in multitransfused Egyptian children with thalassemia,” Annals of Clinical and Laboratory Science, vol. 44, no. 1, pp. 62–66, 2014. View at Google Scholar
  41. A. K. Mansour, R. M. Aly, S. Y. Abdelrazek et al., “Prevalence of HBV and HCV infection among multi-transfused Egyptian thalassemic patients,” Hematology/Oncology and Stem Cell Therapy, vol. 5, no. 1, pp. 54–59, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Dumaidi and A. Al-Jawabreh, “Persistence of anti-HBs among palestinian medical students after 18–22 years of vaccination: a cross-sectional study,” Hepatitis Monthly, vol. 15, no. 11, Article ID e29325, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Sklavounou-Tsouroutsoglou, D. Catriu-Nikolakaki, F. Athanassiadou-Piperopoulou et al., “Hepatitis B vaccination in children with thalassemia in northern Greece,” Biomedicine and Pharmacotherapy, vol. 43, no. 7, pp. 527–530, 1989. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Froutan-Pishbijari, H. Ghofrani, S. Mirmomenm et al., “Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls,” Med Sci Monit, vol. 10, no. 12, pp. CR679–683, 2004. View at Google Scholar
  45. A. Azarkeivan, G. Karimi, M. Shaiegan, M. Maghsudlu, and A. Tabbaroki, “Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect),” Pediatric Hematology and Oncology, vol. 26, no. 4, pp. 195–201, 2009. View at Publisher · View at Google Scholar · View at Scopus